Option Care Health Inc's stock experienced a significant pre-market plunge of 6.36% following the release of its first-quarter financial results.
The US infusion services provider reported Q1 revenue of $1.35 billion, which missed analyst expectations of $1.40 billion. Revenue growth was slow at just 1.3% year-over-year, and the company's CEO described the quarter as a "mixed performance" with unsatisfactory revenue growth momentum.
Adding to investor concerns, the company's full-year 2026 revenue guidance range of $5.68 billion to $5.78 billion fell below the FactSet consensus estimate of $5.94 billion. While Q1 adjusted EBITDA of $104.8 million slightly beat estimates and the company provided 2026 adjusted EPS guidance that was roughly in line with expectations, the revenue disappointment appears to be driving the negative market reaction in pre-market trading.